Joanna Kaczmarczyk’s Post

I am excited to enhance my skills by signing up for the RECOVER Initiative BLS & ALS course today. It's been on my radar for a while, and with the new 2024 guidelines in place, now feels like the perfect time to enrol. Staying current on the latest BLS & ALS practices is crucial, but for me, it underscores the importance of taking a proactive approach to anaesthesia patient care - focusing on Detecting, Preventing, and Mitigating risks. Veterinary nurses and support staff can have a significant impact by implementing some key (yet straightforward) strategies to enhance patient safety and reduce stress levels for clients and the team 🙂. By conducting a thorough patient evaluation (physical assessment, client questioning), identifying risks, using the ASA physical status classification, assessing temperament and BCS, establishing baseline readings, and 'optimising patients' prior to anaesthesia, we can create personalised patient plans that prioritise safety and well-being. - Review past records - Complete the checklist for EVERY patient 💡 Designate a 'patient risk communication champion'! 💡

Curiosity. What I learned today. I got an email from Veterinary Emergency & Critical Care Society (VECCS) today about the new RECOVER guidelines, only to find the RECOVER Initiative released them two weeks ago! Great info here, click their links! Key updates include: • Chest Compression Techniques: Enhanced methods for cats and small dogs to optimize survival during cardiac arrest. • Compression Depths and Techniques: Adjustments tailored to an animal's size and chest shape, improving CPR effectiveness. • Breathing Support Methods: Revised for non-intubated patients, focusing on rescuer safety. • Medication Dosages and Procedures: Updated for more precise and effective treatment during CPR.

News for Veterinarians: EUSAAT Congress 2024 Receives ATF Certification! We are thrilled to inform you that the upcoming EUSAAT Congress has been officially certified by the #ATF (Akademie für tierärztliche Fortbildung) according to §§ 10, 12 of the ATF Statutes. This well-known certification ensures that the congress meets the highest standards of veterinary education and professional development. The certificates will be accepted by the German and Austrian Veterinary Chamber. Participants who attend the entire congress will be recognized with 20 hours of continuing education credit. Additionally, there will be the option to earn credits on a day-to-day basis, allowing for flexible participation tailored to your schedule. This is a fantastic opportunity to enhance your skills, stay updated with the latest advancements in the 3Rs, opportunities for alternatives to animal use, refinement approaches and network with peers and experts in the field. We look forward to welcoming you to the EUSAAT Congress! For more details and to register, visit:  https://lnkd.in/dv3254aT #3R #3Rs #Refinement #Replacement #Reduction #MPS #microphysiologicalsystems #organonachip #spheroids #organoids #novelapproachmethodologies #newapproachmethodologies #EPAA #EUSAAT #NAM #NAMs #ethics #3Rspolicy #animalexperiments #nonanimalmethods #JKU #NIPH #FHKrems #VetMedVienna #IMC #FUBerlin #AIT #DPU

The CMA has confirmed that it will launch a formal market investigation into the veterinary sector.   This is potentially serious for vet practices, as the CMA states it intends to explore whether: - Consumers are getting the information they need, at the right time, to make informed decisions. - A limited choice of vet businesses in certain areas is impacting pet owners. - Profits earned are consistent with the levels expected in a competitive market. - Vet businesses have the incentive and ability to limit consumer choice when providing treatments or recommending related services, particularly when they are part of large integrated groups. - The regulatory framework is preventing the market from functioning as well as it could.   The CMA states that potential remedies could include: - Mandating the provision of certain information to consumers - Imposing maximum prescription fees - Ordering the sale or disposal of a business or assets   Remedies would be legally enforceable. The CMA can also make recommendations to government, e.g. proposing changes to the regulatory framework

Meeting on 3R in September in Austria: The COST Action CA21108 fully supports this meeting on alternatives to animal testing. https://lnkd.in/dSVbQ9w2

💥 A recent global study into mycotoxins into fibre sources in animal feeds has revealed a concerning finding: all samples were contaminated with multiple mycotoxins - a minimum of 3 to a maximum of 11 mycotoxins per sample! This has significant implications for the animals that consume these feeds, particularly sensitive animals like poultry and swine. 🐖 While much attention is rightly given to the mycotoxins we directly ingest, how often do we consider the mycotoxin levels in the feed we provide to our animals? It's an issue that deserves more attention, as it can directly impact animal health and, ultimately, the quality of the products we consume. 👉 Find out more about testing your animal feed at Biorex Food Diagnostics: https://lnkd.in/e_72fmdg Really interesting study from Mycotoxinsite! #Mycotoxins #PatentCo #AnimalFeed

Can’t see Dr. Susan Little in person at WVC? Join us virtually with #vetgirl #veterinary education for this free webinar!

A big 👏🏼 👏🏼 👏🏼 to one of our portfolio companies, MI:RNA, and founder/CEO Eve Hanks! Veterinary Diagnostics Company MI:RNA Raises $4 million Series A Funding MI:RNA, the veterinary diagnostics company using cutting-edge technology and science to transform animal health diagnosis, has secured $4 million in Series A funding. Aiming to change the future of animal health treatments through improved, earlier diagnostics, the capital will be used to continue global growth plans and revolutionize animal health testing, improving diagnosis and wellness among the pet, agriculture, and equine sectors. MI:RNA’s vision is to change the disease diagnosis approach to improve animal outcomes. The merits of MI:RNA technology is scientifically reviewed and proven and has won numerous grants and awards. Funds have been raised from eight investors across three continents, including new investors, NovaQuest (Lead Investor), Kyoritsu Holdings (owner of a Japanese animal health company), VANE (Angel Syndicate), Animal Health Angels, and Companion Fund I, LLC (VC). Existing investors adding to the series A round are Gabriel, Equity Gap and Scottish Enterprise. Eve Hanks, CEO and founder, said: “Following on from our successful seed funding round from Gabriel Investments and Equity Gap, Series A is an important milestone in our global growth plans. We seek to improve health outcomes for animals through earlier disease diagnosis using revolutionary biomarker technology and artificial intelligence. The geographical spread of this investment round reflects the global opportunity for MI:RNA to deploy our platform for better pet outcomes.”     Brian Axe, Managing Director at NovaQuest Capital Management, said: “NovaQuest is extremely excited to lead the Series A with an exceptional syndicate of investors. Eve has assembled an excellent team and strong partners to help bring this disruptive and innovative diagnostic to both Production and Companion Animals. Identifying disease and understanding the stage of disease and progression through cellular mechanisms is the amazing potential miRNAs hold. We believe this technology has tremendous potential.”    Peter Glassman, DVM, Executive Committee Member & Co-founder at Veterinary Angel Network (VANE), said, “Our network of veterinarians, business owners, entrepreneurs, and industry experts are committed to supporting innovation in the animal health field. We invest in businesses that help pet owners, animals, or veterinary teams, and MI:RNA is an exciting investment opportunity at the cutting edge of science and technology. Our members were impressed by the MI:RNA team and the market application opportunity for vet practices globally to detect and stage diseases earlier.”  

Webinar will share “timely and accurate updates” on the current #bluetongue situation, with a focus on what vets need to know about treating cases of #BTV.

I hope everyone is having fun at the #avmaconvention. The expanding knowledge of veterinary medicine is exhilarating. But it sure fuels my anxiety knowing that I can't keep up with it all! Here's my latest cartoon in Veterinary Practice News. #cartoon #comic #veterinarian #veterinary #veterinarypracticenews #vetlife #CE #conference #conferences #vetconferences.